Atlas Trials

VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old

Clinical trial NCT00973895 · COMPLETED

Trial details

NCT number
NCT00973895
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Influenza A Virus, H1N1 SubtypeNovel Swine-Origin
Start date
2009-08-06
Primary completion
2010-09-03
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.